Samuel Caughron News Today

Insurers are investing in lab benefit managers—who, like pharmacy benefit managers, can dictate patient access to services—to navigate demand for genetic tests.

The organization recommended that federal agencies request input from diagnostic industry stakeholders, such as laboratories, manufacturers, and insurers.